COVID-19 epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Line 30: Line 30:
*In a report including approximately 44,500 cases, 87% of the [[Patient|patients]] were between the ages of 30 and 79 years.<ref name="pmid32091533">{{cite journal |vauthors=Wu Z, McGoogan JM |title=Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention |journal=JAMA |volume= |issue= |pages= |date=February 2020 |pmid=32091533 |doi=10.1001/jama.2020.2648 |url=}}</ref>
*In a report including approximately 44,500 cases, 87% of the [[Patient|patients]] were between the ages of 30 and 79 years.<ref name="pmid32091533">{{cite journal |vauthors=Wu Z, McGoogan JM |title=Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention |journal=JAMA |volume= |issue= |pages= |date=February 2020 |pmid=32091533 |doi=10.1001/jama.2020.2648 |url=}}</ref>
*According to the same report mentioned above, 2% of the [[Patient|patients]] were younger than the age of 20 years.
*According to the same report mentioned above, 2% of the [[Patient|patients]] were younger than the age of 20 years.
=== Race ===
* At this point, there seems to be no racial predilection to COVID-19.





Revision as of 20:21, 13 March 2020

COVID-19 Microchapters

Home

Long COVID

Frequently Asked Outpatient Questions

Frequently Asked Inpatient Questions

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating COVID-19 from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Vaccines

Secondary Prevention

Future or Investigational Therapies

Ongoing Clinical Trials

Case Studies

Case #1

COVID-19 epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of COVID-19 epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on COVID-19 epidemiology and demographics

CDC on COVID-19 epidemiology and demographics

COVID-19 epidemiology and demographics in the news

Blogs on COVID-19 epidemiology and demographics

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for COVID-19 epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sabawoon Mirwais, M.B.B.S, M.D.[2]

Overview

Epidemiology and Demorgraphics

Incidence

  • Due to the lack of data at this point, the exact incidence rate of COVID-19 can not be approximated.

Prevalence

Case-fatality rate

  • The case fatality-rate of COVID-19 in the first 99 patients at a Wuhan hospital (the epicenter of the outbreak) was found to be 11%.[2]
  • In a different study comprising of 138 patients infected with COVID-19, the mortality has been established to be 4.3%.[3]
  • Due to inconsistent reporting and lack of organized data, an exact and universal case-fatality rate of COVID-19 is yet to be established.
  • In Wuhan, the case-fatality was 5.8% and in the rest of China it was 0.7%.[4]

Age

  • COVID-19 can affect individuals of any age.
  • Middle aged and elderly population seem to be the most commonly affected.
  • In multiple cohorts of patients hospitalized with confirmed COVID-19, the median age is established to range from 49 to 56 years.[5][6][7]
  • In a report including approximately 44,500 cases, 87% of the patients were between the ages of 30 and 79 years.[8]
  • According to the same report mentioned above, 2% of the patients were younger than the age of 20 years.

Race

  • At this point, there seems to be no racial predilection to COVID-19.






References

  1. https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6. Missing or empty |title= (help)
  2. Huang, Chaolin; Wang, Yeming; Li, Xingwang; Ren, Lili; Zhao, Jianping; Hu, Yi; Zhang, Li; Fan, Guohui; Xu, Jiuyang; Gu, Xiaoying; Cheng, Zhenshun; Yu, Ting; Xia, Jiaan; Wei, Yuan; Wu, Wenjuan; Xie, Xuelei; Yin, Wen; Li, Hui; Liu, Min; Xiao, Yan; Gao, Hong; Guo, Li; Xie, Jungang; Wang, Guangfa; Jiang, Rongmeng; Gao, Zhancheng; Jin, Qi; Wang, Jianwei; Cao, Bin (2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". The Lancet. doi:10.1016/S0140-6736(20)30183-5. ISSN 0140-6736.
  3. Wang, Dawei; Hu, Bo; Hu, Chang; Zhu, Fangfang; Liu, Xing; Zhang, Jing; Wang, Binbin; Xiang, Hui; Cheng, Zhenshun; Xiong, Yong; Zhao, Yan; Li, Yirong; Wang, Xinghuan; Peng, Zhiyong (2020). "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China". JAMA. doi:10.1001/jama.2020.1585. ISSN 0098-7484.
  4. (PDF) https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf. Missing or empty |title= (help)
  5. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (February 2020). "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China". Lancet. 395 (10223): 497–506. doi:10.1016/S0140-6736(20)30183-5. PMID 31986264.
  6. Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J, Yu T, Zhang X, Zhang L (February 2020). "Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study". Lancet. 395 (10223): 507–513. doi:10.1016/S0140-6736(20)30211-7. PMID 32007143 Check |pmid= value (help).
  7. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y, Zhao Y, Li Y, Wang X, Peng Z (February 2020). "Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China". JAMA. doi:10.1001/jama.2020.1585. PMID 32031570 Check |pmid= value (help).
  8. Wu Z, McGoogan JM (February 2020). "Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention". JAMA. doi:10.1001/jama.2020.2648. PMID 32091533 Check |pmid= value (help).